BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7542760)

  • 1. Molecular and functional characterisation of E2F-5, a new member of the E2F family.
    Buck V; Allen KE; Sørensen T; Bybee A; Hijmans EM; Voorhoeve PM; Bernards R; La Thangue NB
    Oncogene; 1995 Jul; 11(1):31-8. PubMed ID: 7542760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
    Ormondroyd E; de la Luna S; La Thangue NB
    Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proto-oncogenic properties of the DP family of proteins.
    Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
    Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P; Müller H; Wagener C; Holm K; Helin K
    Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular and functional characterization of E2F-5 transcription factor.
    Vaishnav YN; Vaishnav MY; Pant V
    Biochem Biophys Res Commun; 1998 Jan; 242(3):586-92. PubMed ID: 9464260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
    Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
    Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster.
    Sawado T; Yamaguchi M; Nishimoto Y; Ohno K; Sakaguchi K; Matsukage A
    Biochem Biophys Res Commun; 1998 Oct; 251(2):409-15. PubMed ID: 9792788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Xenopus laevis DP proteins.
    Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
    Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the Arabidopsis E2F and DP proteins confers their concomitant nuclear translocation and transactivation.
    Kosugi S; Ohashi Y
    Plant Physiol; 2002 Mar; 128(3):833-43. PubMed ID: 11891240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
    Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B; Farmer AA; Lee WH
    Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.